MyChesCo on MSN

FDA clears five-minute lung cancer shot, redefining EGFR treatment

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the ...